Received Aug 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; co-administration of PROQUAD and VARIVAX to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant therapies was not reported. On 10-APR-2025, the patient received inadvertent concomitant administration of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection (exact dose, strength, anatomical route of administration, lot # and expiration date were not reported) and Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (exact dose, strength, anatomical route of administration, lot # and expiration date were not reported) (Accidental overdose). There were no symptomatic events reported (no adverse event). This is an invalid case due to lack of patient's identifiers. Lot number is being requested and will be submitted if received.
Sterile diluent